COVID-19: Protection of IP for AI tools

Nine days before the World Health Organization officially notified the public of a flu-like outbreak in China, BlueDot, a Canadian artificial intelligence (AI) startup, warned its clients of a potential outbreak near a market in Wuhan, China.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Bioinformatics: a guide to IP protection

12 June 2023 AI and computer-related inventions that use biological data are hot property, but what IP is best to protect them? Lauris Kemp, Claire Irvine, and Susan Keston of HGF explain.

Europe

UK implored to back COVID-19 IP waiver at WTO

11 March 2021 The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

Big Pharma

What 2020 means for the life sciences

15 December 2020 Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.

More features

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

GSK escalates mRNA COVID-19 vaccine dispute

Roche resolves cancer test dispute with Stanford affiliated startup

An update on patenting in Ukraine, Russia and Eurasia

COVID-19: Protection of IP for AI tools

More on this story

Editor's picks

Editor's picks

More features